Medtronic has reported that its Endurant II abdominal aortic aneurysm (AAA) stent graft system continues to demonstrate long-term durability and consistent outcomes in a real-world setting. The five-year ENGAGE global registry data were presented for the first time at the 2017 CX Symposium in London, UK.
At the 2017 Charing Cross Symposium (CX; 25–28 April, London, UK), delegates heard brand new data for drug-coated balloons (DCBs) in “wider use” scenarios such as challenging lesions; one-year results for a novel DCB; and late-breaking data on downstream coating effects of various DCBs. Still, 84% of the CX audience said “no” in response to the question: are DCBs equally effective in all lesion subsets? There is still uncertainty in the therapeutic puzzle about which device in the endovascular armamentarium is best suited to treat which lesion.
Tuesday’s CX Aortic Edited Cases session featured exciting and engaging standing-room only case presentations, including Andrew Holden’s (Auckland, New Zealand) first-in-man implantation of the Ovation Alto (Endologix). Covering thoracic, juxtarenal and abdominal cases, the packed-out session explored innovative techniques, novel devices and a veritable array of practical tips and tricks, offering an invaluable resource for delegates.
Lombard Medical has now enrolled and treated the first patient in its global registry to evaluate its Altura endograft system.
The particular complexities of dealing with paediatric vessels were discussed in depth at Tuesday’s varied and informative CX Paediatric Vascular Emergencies and Case Presentations session. Covering topics as diverse as acute ischaemia from pre-term to infant and treatment for battlefield trauma in children, the session was one of the highlights of the day.
In Tuesday’s CX Congenital Vascular Malformations session, delegates heard about how approaching congenital vascular malformations with systematic pathways of care and classification systems can greatly assist physicians in achieving consistently successful positive outcomes.
Getinge has announced that, in order to better convey its customer offering and strengthen its position, it has grouped its portfolio under one single brand – Getinge. The company has also now launched the Advanta V12 32mm balloon-expandable covered stent.
Bluegrass Vascular Technologies has enrolled over one third of its patients in the company’s post-market SAVE (Surfacer System to Facilitate Access in Venous Occlusions) clinical study. The SAVE study is an international, prospective, multicentre clinical follow-up study designed to confirm clinical performance and safety of the Surfacer inside-out access catheter system, a device indicated for obtaining central venous access to facilitate catheter insertion into the central venous system in patients with chronically occluded veins.
Ra Medical Systems and bo medical technologies, have announced the launch of the Dabra atherectomy system for cardiovascular and Pharos excimer laser for dermatology in Europe.
PinnacleHealth CardioVascular Institute has enrolled the first US patient in a trial assessing the safety and effectiveness of a new type of approach for blockages in the leg artery.
QXMédical has announced its sponsorship of EVARplanning.com, an online tool which helps vascular and cardiovascular specialists plan complex endovascular aneurysm repair (EVAR) procedures.
Essential Medical has announced the publication of the MANTA CE marking study results in JACC Interventions titled: “Percutaneous plug-based arteriotomy closure device for large-bore access”.
Lombard Medical and MicroPort Scientific Corporation have finalised the definitive agreements to their strategic partnership first announced on 19 December 2016.
iVascular has obtained CE mark for the thrombus extraction catheter Capturer 7F.
Endologix has announced today that the first patients were treated in the ELEVATE (Expanding patient applicability with polymer sealing Ovation Alto stent graft) investigational device exemption (IDE) clinical study, the company’s pivotal clinical trial to evaluate the safety and effectiveness of the Ovation Alto abdominal stent graft system for the repair of infrarenal abdominal aortic aneurysms.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos